Scarica l'app Stockscreener
0.1297
2.92%
-0.0039
Dopo l'orario di chiusura:
.13
0.0003
+0.23%
Precedente Chiudi:
$0.1336
Aprire:
$0.1343
Volume 24 ore:
1.47M
Relative Volume:
0.28
Capitalizzazione di mercato:
$3.71M
Reddito:
-
Utile/perdita netta:
$-8.74M
Rapporto P/E:
-0.0633
EPS:
-2.05
Flusso di cassa netto:
$-8.25M
1 W Prestazione:
-2.70%
1M Prestazione:
-24.33%
6M Prestazione:
-97.33%
1 anno Prestazione:
-99.69%
Intervallo 1D:
$0.1231
$0.1343
Intervallo di 1 settimana:
$0.1231
$0.1398
Portata 52W:
$0.1231
$62.60
Glucotrack Inc Stock (GCTK) Company Profile
Nome
Glucotrack Inc
Settore
Industria
Telefono
972 (8) 675-7878
Indirizzo
301 RT 17 NORTH, RUTHERFORD
Confronta GCTK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
0.1297 | 3.82M | 0 | -8.74M | -8.25M | -2.05 |
|
ISRG
Intuitive Surgical Inc
|
552.34 | 193.38B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
172.59 | 49.12B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.94 | 42.79B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
244.79 | 35.61B | 5.02B | 1.31B | 1.56B | 8.91 |
|
BAX
Baxter International Inc
|
30.50 | 15.46B | 11.89B | -560.00M | 191.00M | -1.10 |
Glucotrack Inc Borsa (GCTK) Ultime notizie
GCTK stock plunges to 52-week low, hits $0.13 - Investing.com Australia
GCTK stock plunges to 52-week low, hits $0.13 By Investing.com - Investing.com UK
Upcoming Benzinga Webinar With Glucotrack To Discuss The Potential Of Its Innovative CBGM Technology To Transform Diabetes Care And Patient Lives - FinancialContent
Glucotrack appoints new board member with diabetes tech expertise By Investing.com - Investing.com South Africa
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD - The Manila Times
GCTKGlucotrack Latest Stock News & Market Updates - Stock Titan
GlucoTrack (NASDAQ:GCTK) Trading Down 0.2% – Time to Sell? - Defense World
GlucoTrack Approves Key Proposals at Annual Meeting - TipRanks
GCTK stock plunges to 52-week low, touches $0.13 - Investing.com Australia
GCTK stock plunges to 52-week low, touches $0.13 By Investing.com - Investing.com Nigeria
GlucoTrack Establishes Patient Advisory Board for CBGM - TipRanks
Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development - The Manila Times
Glucotrack, Inc. Forms Patient Advisory Board to Enhance Development of Continuous Blood Glucose Monitor - Nasdaq
Groundbreaking 3-Year Implantable Glucose Monitor Gets Patient-Led Development at Glucotrack - Stock Titan
Glucotrack Reports Q1 2025 Financial Results and Progress - TipRanks
Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times
Innovative Continuous Blood Glucose Monitor Shows Promise in First Human Trial - citybuzz -
GlucoTrack Reports Q1 2025 Financial Results and Progress - TipRanks
Glucotrack, Inc. SEC 10-Q Report - TradingView
Glucotrack, Inc. Advances Continuous Blood Glucose Monitoring Technology with Clinical Study Initiation in Australia by Q3 2025 - Nasdaq
Glucotrack Reports First Quarter 2025 Financial Results And Recent Corporate Highlights - marketscreener.com
Breakthrough: Glucotrack's Implantable Diabetes Monitor Hits Clinical Milestone, FDA Decision Expected Q4 - Stock Titan
Glucotrack gains HREC approval for clinical study of CBGM device - Yahoo Finance
First-In-Human Study In The Bag, Glucotrack Gears Up For Long-Term Trial Of Potentially Groundbreaking Continuous Blood Glucose Monitor For Diabetes Patients - FinancialContent
Certain Options of GlucoTrack, Inc. are subject to a Lock-Up Agreement Ending on 14-MAY-2025. - marketscreener.com
Certain Common Stock of GlucoTrack, Inc. are subject to a Lock-Up Agreement Ending on 14-MAY-2025. - marketscreener.com
GlucoTrack Gains Approval for Long-Term Clinical Study - TipRanks
Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor - The Manila Times
Geode Capital Management LLC Increases Stock Holdings in GlucoTrack, Inc. (NASDAQ:GCTK) - Defense World
GlucoTrack Inc (GCTK) can make a big difference with a little luck - Sete News
Medtech CEO Shares Lessons From FIH Implantable Glucose Monitor Trial - Clinical Leader
GlucoTrack Releases Investor Presentation on April 29 - TipRanks
GlucoTrack Inc (NASDAQ:GCTK) stock crossing the finish line today - uspostnews.com
Can GlucoTrack Inc Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com
Now Is The Time To Build A Position In GlucoTrack Inc (NASDAQ:GCTK) - Marketing Sentinel
Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights - ADVFN
It makes sense and dollars to buy GlucoTrack Inc (GCTK) stock - Sete News
Pre-market Movers: OPTN, WINT, AKBA, GCTK... - RTTNews
GlucoTrack Joins EU Bionic Pancreas Initiative - TipRanks
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas - The Manila Times
Major Breakthrough: Glucotrack Selected for EU's Revolutionary Bionic Pancreas Project - Stock Titan
Glucotrack to bring CBGM to bionic pancreas initiative in Europe - Drug Delivery Business
Investing in GlucoTrack Inc (GCTK) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com
GCTK stock plunges to 52-week low of $0.15 amid market turmoil By Investing.com - Investing.com South Africa
GCTK stock plunges to 52-week low of $0.15 amid market turmoil - Investing.com India
Glucotrack faces Nasdaq delisting over share price rule - Investing.com Australia
Glucotrack faces Nasdaq delisting over share price rule By Investing.com - Investing.com South Africa
Glucotrack partners with OneTwo Analytics for AI diabetes data analysis By Investing.com - Investing.com South Africa
6 Alternatives to Apple’s Non-Invasive Glucose Monitoring You Can Try Now - The Mac Observer
GlucoTrack Partners with OneTwo Analytics for AI-Driven Insights - TipRanks
Glucotrack partners with OneTwo Analytics for AI diabetes data analysis - Investing.com Australia
Glucotrack Inc Azioni (GCTK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.66%
1.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):